✉news HealthMedicine first seen 6 h ago, last 1 h ago, peak #21
Subcutaneous Treatment Improves Ocular Myasthenia Gravis Scores
Original: Ocular Myasthenia Gravis Scores Improve With Subcutaneous Treatment
New reporting indicates that patients with ocular myasthenia gravis saw improvements in disease scores when treated with a subcutaneous therapy. The finding suggests an injected formulation may offer benefit for the eye-related form of the autoimmune condition, which causes drooping eyelids and double vision. Details on trial size, drug name and significance of the score changes remain limited in early coverage.
Why now: Fresh medical news of a potentially easier treatment option for a chronic autoimmune disease draws attention from patients and clinicians.
ocular myasthenia gravisMedPage Today
Rank over time, top of the chart is #1. 4 snapshots from 6 h ago to 1 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/1023847